Last Updated: August 9, 2026

List of Excipients in API naloxone

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing naloxone

Subscribe to access the full database, or Start Trial
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Summit Biosciences Inc	NALOXONE	naloxone	43674-003	GLYCERIN
Summit Biosciences Inc	NALOXONE	naloxone	43674-003	HYDROCHLORIC ACID
Summit Biosciences Inc	NALOXONE	naloxone	43674-003	SODIUM HYDROXIDE
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Excipients in ANDA-approved (generic) drugs containing naloxone

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC	Excipient
Amneal Pharmaceuticals NY LLC	naloxone	60219-2104	BENZALKONIUM CHLORIDE
Amneal Pharmaceuticals NY LLC	naloxone	60219-2104	EDETATE DISODIUM
Amneal Pharmaceuticals NY LLC	naloxone	60219-2104	HYDROCHLORIC ACID
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for naloxone

Excipient focus: ALCOHOL

naloxone drug variants containing ALCOHOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Hikma Specialty USA Inc	naloxone hcl	59467-679
>Company	>Ingredient	>NDC

naloxone drug variants not containing ALCOHOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Summit Biosciences Inc	naloxone	43674-003
Amneal Pharmaceuticals NY LLC	naloxone	60219-2104
HF Acquisition Co LLC DBA Health First	naloxone hci	51662-1242
>Company	>Ingredient	>NDC

Excipient focus: BENZALKONIUM CHLORIDE

naloxone drug variants containing BENZALKONIUM CHLORIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Amneal Pharmaceuticals NY LLC	naloxone	60219-2104
Teva Pharmaceuticals USA Inc	naloxone hydrochloride	0093-2165
Walgreen Co	naloxone hydrochloride	0363-2140
>Company	>Ingredient	>NDC

naloxone drug variants not containing BENZALKONIUM CHLORIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Summit Biosciences Inc	naloxone	43674-003
HF Acquisition Co LLC DBA Health First	naloxone hci	51662-1242
Hikma Specialty USA Inc	naloxone hcl	59467-679
>Company	>Ingredient	>NDC

Excipient focus: EDETATE DISODIUM

naloxone drug variants containing EDETATE DISODIUM

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Amneal Pharmaceuticals NY LLC	naloxone	60219-2104
Hikma Specialty USA Inc	naloxone hcl	59467-679
Teva Pharmaceuticals USA Inc	naloxone hydrochloride	0093-2165
>Company	>Ingredient	>NDC

naloxone drug variants not containing EDETATE DISODIUM

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Summit Biosciences Inc	naloxone	43674-003
HF Acquisition Co LLC DBA Health First	naloxone hci	51662-1242
Scienture LLC	naloxone hcl	83245-003
>Company	>Ingredient	>NDC

Excipient focus: GLYCERIN

naloxone drug variants containing GLYCERIN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Summit Biosciences Inc	naloxone	43674-003
Scienture LLC	naloxone hcl	83245-003
Summit Biosciences Inc	naloxone hydrochloride	43674-004
>Company	>Ingredient	>NDC

naloxone drug variants not containing GLYCERIN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Amneal Pharmaceuticals NY LLC	naloxone	60219-2104
HF Acquisition Co LLC DBA Health First	naloxone hci	51662-1242
Hikma Specialty USA Inc	naloxone hcl	59467-679
>Company	>Ingredient	>NDC

Excipient focus: HYDROCHLORIC ACID

naloxone drug variants containing HYDROCHLORIC ACID

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Summit Biosciences Inc	naloxone	43674-003
Amneal Pharmaceuticals NY LLC	naloxone	60219-2104
HF Acquisition Co LLC DBA Health First	naloxone hci	51662-1242
>Company	>Ingredient	>NDC

naloxone drug variants not containing HYDROCHLORIC ACID

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Lake Erie Medical DBA Quality Care Products LLC	naloxone hydrochloride	55700-457
Mylan Institutional LLC	naloxone hydrochloride	67457-992
International Medication Systems Ltd	naloxone hydrochloride	76329-3669
>Company	>Ingredient	>NDC

Excipient focus: METHYLPARABEN

naloxone drug variants containing METHYLPARABEN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Baxter Healthcare Corporation	naloxone hydrochloride	36000-310
HF Acquisition Co LLC DBA HealthFirst	naloxone hydrochloride	51662-1385
HF Acquisition Co LLC DBA HealthFirst	naloxone hydrochloride	51662-1426
>Company	>Ingredient	>NDC

naloxone drug variants not containing METHYLPARABEN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Summit Biosciences Inc	naloxone	43674-003
Amneal Pharmaceuticals NY LLC	naloxone	60219-2104
HF Acquisition Co LLC DBA Health First	naloxone hci	51662-1242
>Company	>Ingredient	>NDC

Excipient focus: NITROGEN

naloxone drug variants containing NITROGEN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Dr Reddy's Laboratories Inc	naloxone hydrochloride	43598-750
HF Acquisition Co LLC DBA HealthFirst	naloxone hydrochloride	51662-1529
Meitheal Pharmaceuticals Inc	naloxone hydrochloride	71288-814
>Company	>Ingredient	>NDC

naloxone drug variants not containing NITROGEN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Summit Biosciences Inc	naloxone	43674-003
Amneal Pharmaceuticals NY LLC	naloxone	60219-2104
HF Acquisition Co LLC DBA Health First	naloxone hci	51662-1242
>Company	>Ingredient	>NDC

Excipient focus: PROPYLENE GLYCOL

naloxone drug variants containing PROPYLENE GLYCOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Hikma Specialty USA Inc	naloxone hcl	59467-679
>Company	>Ingredient	>NDC

naloxone drug variants not containing PROPYLENE GLYCOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Summit Biosciences Inc	naloxone	43674-003
Amneal Pharmaceuticals NY LLC	naloxone	60219-2104
HF Acquisition Co LLC DBA Health First	naloxone hci	51662-1242
>Company	>Ingredient	>NDC

Excipient focus: PROPYLPARABEN

naloxone drug variants containing PROPYLPARABEN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Baxter Healthcare Corporation	naloxone hydrochloride	36000-310
HF Acquisition Co LLC DBA HealthFirst	naloxone hydrochloride	51662-1385
HF Acquisition Co LLC DBA HealthFirst	naloxone hydrochloride	51662-1426
>Company	>Ingredient	>NDC

naloxone drug variants not containing PROPYLPARABEN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Summit Biosciences Inc	naloxone	43674-003
Amneal Pharmaceuticals NY LLC	naloxone	60219-2104
HF Acquisition Co LLC DBA Health First	naloxone hci	51662-1242
>Company	>Ingredient	>NDC

Excipient focus: SODIUM CHLORIDE

naloxone drug variants containing SODIUM CHLORIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Amneal Pharmaceuticals NY LLC	naloxone	60219-2104
HF Acquisition Co LLC DBA Health First	naloxone hci	51662-1242
Teva Pharmaceuticals USA Inc	naloxone hydrochloride	0093-2165
>Company	>Ingredient	>NDC

naloxone drug variants not containing SODIUM CHLORIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Summit Biosciences Inc	naloxone	43674-003
Hikma Specialty USA Inc	naloxone hcl	59467-679
Scienture LLC	naloxone hcl	83245-003
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

naloxone drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Summit Biosciences Inc	naloxone	43674-003
Hikma Specialty USA Inc	naloxone hcl	59467-679
Scienture LLC	naloxone hcl	83245-003
>Company	>Ingredient	>NDC

naloxone drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Amneal Pharmaceuticals NY LLC	naloxone	60219-2104
HF Acquisition Co LLC DBA Health First	naloxone hci	51662-1242
Teva Pharmaceuticals USA Inc	naloxone hydrochloride	0093-2165
>Company	>Ingredient	>NDC

Excipient focus: TRISODIUM CITRATE DIHYDRATE

naloxone drug variants containing TRISODIUM CITRATE DIHYDRATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Summit Biosciences Inc	naloxone	43674-003
Scienture LLC	naloxone hcl	83245-003
Summit Biosciences Inc	naloxone hydrochloride	43674-004
>Company	>Ingredient	>NDC

naloxone drug variants not containing TRISODIUM CITRATE DIHYDRATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Amneal Pharmaceuticals NY LLC	naloxone	60219-2104
HF Acquisition Co LLC DBA Health First	naloxone hci	51662-1242
Hikma Specialty USA Inc	naloxone hcl	59467-679
>Company	>Ingredient	>NDC

Excipient focus: WATER

naloxone drug variants containing WATER

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Summit Biosciences Inc	naloxone	43674-003
Amneal Pharmaceuticals NY LLC	naloxone	60219-2104
HF Acquisition Co LLC DBA Health First	naloxone hci	51662-1242
>Company	>Ingredient	>NDC

naloxone drug variants not containing WATER

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Hospira Inc	naloxone hydrochloride	0409-1782
Baxter Healthcare Corporation	naloxone hydrochloride	43066-142
HF Acquisition Co LLC DBA HealthFirst	naloxone hydrochloride	51662-1238
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.